Cardiac Complications following Creation of Arteriovenous Access in Medicare Beneficiaries with ESKD
Kidney360 · 10.11.2026
DOI: 10.34067/kid.0000001419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 10.11.2026. Verfasst von Helena Smith und 4 weiteren Autor:innen. Beteiligte Einrichtung: Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Arteriovenous fistulas (AVFs) and grafts (AVGs) are the preferred long-term hemodialysis access for the majority of patients, but produce hemodynamic changes that contribute to cardiac complications including heart failure, pulmonary hypertension, and atrial arrhythmia. This cohort study leverages nationwide claims data to examine adverse cardiac events associated with AVGs and AVFs among patients with ESKD.
Methods
We performed a retrospective cohort study using 100% Medicare fee-for-service claims to identify adults with ESKD undergoing AVF or AVG creation from 2017−2024. The primary outcome was hospitalization for a composite adverse cardiac event (heart failure, pulmonary hypertension, or atrial fibrillation or flutter) within 1 year. Secondary outcomes included the composite outcome through 5 years, its individual components, all-cause hospitalization, and flow-reduction procedures. Cumulative incidence functions were estimated using Fine-Gray subdistribution hazard models. Independent variable analyses were conducted for the primary outcome.
Results
We identified 210,002 accesses (mean age 66.3 years; 43% female) including 147,709 (70%) AVFs and 62,293 (30%) AVGs. AVG recipients had a greater burden of baseline comorbidity and cardiovascular disease. Through 1 year, the cumulative incidence of hospitalization for an adverse cardiac event was 40% (AVF 39%, AVG 44%, P < .001), constituting 61% of all-cause hospitalizations. Heart failure predominated (AVF 33%, AVG 37%, P < .001), followed by atrial fibrillation or flutter (AVF 19%, AVG 21%, P < .001), and pulmonary hypertension (AVF 8%, AVG 9%, P < .001). Older age (≥ 50 years), AVG creation, pre-existing pulmonary hypertension, and atrial arrhythmia were independently associated with a higher hazard of the primary outcome (P < .05).
Conclusions
The high rate of hospitalization for adverse cardiac events in the first year after arteriovenous access creation supports consideration of strategies (e.g., lower-flow forearm access, flow-volume surveillance) to mitigate the hemodynamic consequences of long-term arteriovenous access.
Autor:innen und Institutionen
- Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Division of Vascular & Endovascular Surgery and the Center for Surgery and Public Health, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
- Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Helena Smith, Chien-Yu Huang, Eric A Secemsky, Mohamad A Hussain
Zitieren
APA
Smith, H., Huang, C. Y., Salomon, B., Secemsky, E. A., & Hussain, M. A. (2026). Cardiac Complications following Creation of Arteriovenous Access in Medicare Beneficiaries with ESKD. Kidney360. https://doi.org/10.34067/kid.0000001419
Vancouver
Smith H, Huang CY, Salomon B, Secemsky EA, Hussain MA. Cardiac Complications following Creation of Arteriovenous Access in Medicare Beneficiaries with ESKD. Kidney360. 2026. doi:10.34067/kid.0000001419
BibTeX
@article{Smith2026,
author = {Smith, Helena and Huang, Chien-Yu and Salomon, Brett and Secemsky, Eric A and Hussain, Mohamad A},
title = {Cardiac Complications following Creation of Arteriovenous Access in Medicare Beneficiaries with ESKD},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001419}
}
EUVIMED